Menu

CME Corner

Active Programs

Best Practices in the Use of Incretin-based Therapies in the Management of Type 2 Diabetes (AANP Program ID 16032139)

This activity will address glycemic variability and cardiovascular considerations in patients with T2DM and examine therapeutic management, with a particular focus on the optimal use of GLP-1 receptor agonists and DPP-4 inhibitors. *Learners will be redirected to the AANP website. ...

  • Online Presentation Online Presentation
  • AANP

Using GLP-1 Receptor Agonists to Optimize Glycemic Control

The management of T2DM remains a major challenge as many patients continue to struggle with achieving glycemic control. Glucagon-like peptide 1 (GLP-1) receptor agonists, one of the newer drug classes for the treatment of T2DM, have been shown to be safe and effective in improving glycemic control. This activity will examine the use of GLP-1 receptor agonists in clinical practice, including long-t ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Using GLP-1 Receptor Agonists to Reduce Cardiovascular Risk

The management of T2DM remains a major challenge as many patients continue to struggle with achieving therapeutic targets, including control of A1c levels, LDL cholesterol, and blood pressure. Glucagon-like peptide 1 (GLP-1) receptor agonists, one of the newer drug classes for the treatment of T2DM, may offer beneficial effects on cardiovascular risk factors. This activity will examine the use of ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Team-Based Approaches to Enhancing Care for Older Adults With T2DM

A collaborative and engaged style of care planning generally provides the best results for patients. Physicians, NPs, PAs, pharmacists, nurses, and others who care for and support older adults with type 2 diabetes (T2DM) can be most effective working in a team, especially when managing individuals with multiple chronic problems. This activity examines the key features of a holistic, relationship-b ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ACPE
  • ANCC

Individualizing Treatment Plans for Older Adults with T2DM

Approximately 26% of adults over age 65 in the US (11.2 million people) have diabetes. This is a heterogeneous population that includes individuals residing independently in communities, in assisted living, and in skilled nursing facilities. Management of diabetes in older adults should be carefully tailored, taking into account these variables. All members of the care team, including physicians, ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ACPE
  • ANCC

Perspectives on the Care of Older Adults with T2DM: A Multidisciplinary Discussion

This activity features an engaging multidisciplinary faculty discussion about special considerations in the care of older adults with T2DM. Many older adults with T2DM are experiencing negative health consequences that could be prevented or improved with optimal evidence-based care. This is a heterogeneous population that includes individuals residing independently in communities, in assisted livi ...

  • Video Roundtable Video Roundtable
  • ACCME
  • ACPE
  • ANCC

Treatment Patterns in Family Medicine: Clinical Perspectives on Incretin-Based Therapies in the Management of T2DM

The management of type 2 diabetes mellitus (T2DM) remains a major clinical challenge as many patients continue to struggle with achieving therapeutic goals. The goal of this activity is to improve knowledge and competency among primary care clinicians with regard to addressing glycemic variability in patients with T2DM through optimal therapeutic management, with a particular focus on the optimal ...

  • i-Newsletter
  • AAFP
  • AANP
  • AAPA

Expired Programs

Clinical Insights in Pediatrics: Early Detection and Optimal Treatment of Growth Disorders in Children

Approximately 10,000 to 15,000 children in the United States have problems with growth. Recombinant human growth hormone (GH) has been approved by the FDA for growth disorders in children. Though the FDA has specific indications for GH therapy, growth disorders are typically marked by either growth failure or short stature defined as 2 standard deviations or more below the normal mean for age and ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Team-Based Approaches to Help Older Adults With Type 2 Diabetes Achieve Individualized Glycemic Goals

A CPE-certified online monograph with highlights from the American Society of Consultant Pharmacists workshop. Many older adults with T2DM are experiencing negative health consequences that could be prevented or improved with optimal evidence-based care. The goal of this monograph is to help consultant and senior care pharmacists achieve greater competency in participating in team-based care a ...

  • e-Monograph
  • ACPE
Main Menu
EDITOR'S PICKS